Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma

2012, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009, Neuro Oncol, 14, v1, 10.1093/neuonc/nos218

2010, Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology, Neuro Oncol, 12, 520, 10.1093/neuonc/nop066

2010, Pathological classification and molecular genetics of meningiomas, J Neurooncol, 99, 379, 10.1007/s11060-010-0342-2

2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4

2016, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, 131, 803, 10.1007/s00401-016-1545-1

2008, Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria, Neurosurg Focus, 24, E3, 10.3171/FOC/2008/24/5/E3

2011, Anatomic location is a risk factor for atypical and malignant meningiomas, Cancer, 117, 1272, 10.1002/cncr.25591

2007, Stereotactic radiation treatment for recurrent nonbenign meningiomas, J Neurosurg, 106, 846, 10.3171/jns.2007.106.5.846

2008, Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features, J Neurol Neurosurg Psychiatry, 79, 574, 10.1136/jnnp.2007.121582

1957, The recurrence of intracranial meningiomas after surgical treatment, J Neurol Neurosurg Psychiatry, 20, 22, 10.1136/jnnp.20.1.22

2015, Extent of resection and overall survival for patients with atypical and malignant meningioma, Cancer, 121, 4376, 10.1002/cncr.29639

2013, Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma, Acta Neurochir (Wien), 155, 1385, 10.1007/s00701-013-1775-0

2013, The role of adjuvant radiotherapy in atypical meningioma, J Neurooncol, 115, 241, 10.1007/s11060-013-1219-y

2009, Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation, Neurosurgery, 64, 56, 10.1227/01.NEU.0000330399.55586.63

2012, The role of radiotherapy following gross-total resection of atypical meningiomas, J Neurosurg, 117, 679, 10.3171/2012.7.JNS112113

2014, Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma, Neuro Oncol, 16, 1547, 10.1093/neuonc/nou098

2014, Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection, Neurosurgery, 75, 356, 10.1227/NEU.0000000000000462

2014, Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection, Neurosurgery, 75, 347, 10.1227/NEU.0000000000000461

2011, Radiotherapy for atypical meningiomas, J Neurosurg, 115, 811, 10.3171/2011.5.JNS11112

2010, Treatment of atypical meningioma, J Clin Neurosci, 17, 1362, 10.1016/j.jocn.2010.03.036

2014, Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment, Acta Neurochir (Wien), 156, 1475, 10.1007/s00701-014-2156-z

2016, WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment, J Neurooncol, 129, 337, 10.1007/s11060-016-2181-2

2012, Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)–based analysis, J Neurosurg, 117, 669, 10.3171/2012.7.JNS111439

2008, Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?, Br J Neurosurg, 22, 520, 10.1080/02688690802308687

2006, Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification, J Neurol Neurosurg Psychiatry, 77, 767, 10.1136/jnnp.2005.077974

2014, Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review, Neuro Oncol, 16, 628, 10.1093/neuonc/nou025

Surgeons. ACo

Cancer. ACoSCo

2001, Stereotactic proton beam therapy of skull base meningiomas, Int J Radiat Oncol Biol Phys, 49, 99, 10.1016/S0360-3016(00)01457-7

1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X

Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539

2015, Atypical meningiomas: recurrence, reoperation, and radiotherapy, World Neurosurg, 84, 839, 10.1016/j.wneu.2015.04.033

1998, MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors, Hum Pathol, 29, 1420, 10.1016/S0046-8177(98)90010-7

2002, Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma, Cancer, 94, 1538, 10.1002/cncr.10351

2014, Surgical experience of infratentorial meningiomas: clinical series at a single institution during the 20-year period, J Korean Neurosurg Soc, 55, 321, 10.3340/jkns.2014.55.6.321